Poor uptake of hepatitis B vaccine in India has several causes, study findsBMJ 2013; 346 doi: http://dx.doi.org/10.1136/bmj.f3596 (Published 06 June 2013) Cite this as: BMJ 2013;346:f3596
- Cheryl Travasso
Poor management of vaccine stocks, poor record keeping, lack of staff training, and use of multidose vials were among the main reasons for low coverage of the hepatitis B vaccine in 10 states across India, researchers have found.
India is home to 11% of the world’s people with chronic hepatitis B and has between 100 000 and 200 000 deaths from hepatocellular carcinoma or cirrhosis each year. To tackle the disease, India introduced the hepatitis B vaccine across 10 states in …
Log in using your username and password
Log in through your institution
Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
Sign up for a free trial